EchoIQ - FloodGate Medical

AI insight to identify the patients who need you most

About Us

At Echo IQ, we use the AI-powered technology in EchoSolv to enhance the diagnosis of structural heart disease. Our mission is to help improve the lives of people by supporting earlier, more accurate detection of a number of life-threatening but often treatable conditions.

The Echo IQ platform applies innovative methodologies and a proprietary algorithm to produce risk assessments for patients using their echocardiographic measurements. We harness the power of AI to produce consistent outputs at speed, and without bias. Applied to the identification of aortic stenosis, for example, EchoSolv has been designed to identify patients at risk of mortality who might benefit from further clinical review. We are proud to be applying leading-edge technologies, led by thought-leaders in cardiology, to deliver new solutions in cardiac care.

Look at the Leaders of Echo IQ

Nick Lubbers

President & GM, U.S

Dustin Haines

Chief Executive Officer

Sam Dribin

Chief Technology Officer

Featured Services and Innovations

AI Model

– Built from more than 200 million echo measurements, EchoSolv AS analyzes measurements (not images) to detect patterns associated with poor survival—without relying on LVOT.

– 1 in 2 patients identified by EchoSolv AS as having elevated mortality did not meet guidelines.

– 5-year mortality in the severe AS phenotype was only 3% lower than guideline-defined severe AS (73.5% vs. 75.9%).

AS is a clinical and economic crisis

– About 4.3 million American adults are living with aortic valve disease

– 25% will be hospitalized annually if left untreated

– Delayed treatment results in $10,080 in excess healthcare utilization per patient over one year

– Patients who go undetected have a higher probability of acute decompensation, which carries approximately $15,000 higher healthcare costs per patient annually

– This translates to an estimated $10.2 billion in direct healthcare costs annually in the U.S. alone

Seamless setup, minimal lift

EchoSolv AS easily slots into your existing workflow, no IT overhaul necessary.

– No EMR changes required

– HIPAA-compliant and SOC 2 Type II-certified

– API-ready for easy connection with PACS or echo reporting systems

Company Spotlight Video

Science & Research

Echo IQ aims to support closing the gap in diagnosis and treatment of structural heart disease, thus saving lives and improving the health and well-being of patients worldwide.

We feel that it is important to share published research that supports our mission and provides substantial evidence of our method’s benefits. It is important for us that this published research is easily accessible.

Our solutions are underpinned by research and academic rigour. These selected journal articles illustrate the extent of the problem and shine a light on the potential for artificial intelligence to have a positive impact in the sector. By reading this published research, you’ll gain knowledge and insight regarding AI and machine learning in the field of medicine.

Additionally, EchoIQ and NEDA are working together through an agreement that gives EchoIQ exclusive access to unlimited usage of the data for the purposes of commercialization. Through this agreement EchoIQ and NEDA continue to work together to identify research opportunities exploring various forms of structural heart disease as part of our ongoing effort to help improve patients’ lives around the world.

Looking to stand out from the crowd during your job search? Click below to gain access to our top tips & tools for candidates during the hiring process!

Recruiting Done Differently.

Improving lives by uniting great people with great companies.

Sign up for our Monthly Newsletter

We’re committed to sharing up-to-date industry insights, our newest career opportunities, and valuable tools to support you throughout your next job search. Let’s stay connected!